Dr. Reddy's Lab launches Hydroxychloroquine Sulfate Tablets in US market

11 Jul 2018 Evaluate

Dr. Reddy's Laboratories has launched Hydroxychloroquine Sulfate Tablets USP, 200 mg, a therapeutic equivalent generic version of Plaquenil Tablets, in the US market, approved by the US Food and Drug Administration (USFDA).

The Plaquenil brand and generic had US sales of approximately $215 million MAT for the most recent twelve months ending in May 2018 according to IMS Health. The company’s Hydroxychloroquine Sulfate Tablets are available in 200 mg tablets in the bottle count sizes of 100 and 500. Plaquenil is a trademark of Concordia International Corp.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1175.55 -10.90 (-0.92%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×